Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Net Income towards Common Stockholders (2010 - 2025)

Siga Technologies' (SIGA) quarterly Net Income towards Common Stockholders came in at -$6.4 million in Q3 2025, down 573.67% on a YoY basis from $1.3 million in Q3 2024, and down 117.95% quarter-over-quarter from $35.5 million in Q2 2025.

Analysis

Siga Technologies (SIGA) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Net Income towards Common Stockholders for 16 consecutive years, with -$6.4 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Net Income towards Common Stockholders fell 573.67% year-over-year to -$6.4 million; the trailing twelve-month figure through Sep 2025 stood at $74.5 million (down 13.05% YoY), and the FY2024 full-year result was $59.2 million, down 13.01% from the prior year.
  • Net Income towards Common Stockholders retreated to -$6.4 million in Q3 2025 per SIGA's latest filing, from $35.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $73.4 million in Q4 2021 and bottomed at -$6.4 million in Q3 2025.
  • Historically, Net Income towards Common Stockholders has averaged $13.6 million across 5 years, with a median of -$258928.0 in 2021.
  • The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders soared 9000.73% in 2023, then slumped 573.67% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at $73.4 million in 2021, then sank by 101.11% to -$811794.0 in 2022, then jumped by 9000.73% to $72.3 million in 2023, then tumbled by 36.67% to $45.8 million in 2024, then tumbled by 113.91% to -$6.4 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$6.4 million, $35.5 million, and -$370415.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 5.53 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 3.62 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 3.26 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -238.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 398.69 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -644.37 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 333.00 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -6.37 Mn
Jun 30, 2025 35.47 Mn
Mar 31, 2025 -370,415.00
Dec 31, 2024 45.76 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 10.28 Mn
Dec 31, 2023 72.26 Mn
Sep 30, 2023 -393,066.00
Jun 30, 2023 -2.88 Mn
Mar 31, 2023 -917,677.00
Dec 31, 2022 -811,794.00
Sep 30, 2022 33.04 Mn
Jun 30, 2022 1.99 Mn
Mar 31, 2022 -361,049.00
Dec 31, 2021 73.38 Mn
Sep 30, 2021 -3.11 Mn
Jun 30, 2021 -258,928.00
Mar 31, 2021 -1.73 Mn
Dec 31, 2020 20.16 Mn